slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 210,571-210,600
Pages 10,126
Rows per page 30
Component
210,571-210,600 of 303,780
13
Data presented in two tables comparing integrated safety data from glioma patients and a healthy adult study.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
14
The table compares 'All patients' against 'RANO HGG Responders' and 'RANO HGG and/or LGG Responders' across survival and clinical metrics.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
15
The table uses a color-coded heatmap (green/pink) to indicate positive vs negative characteristics of trial design and outcomes.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
16
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
17
The slide uses a process flow diagram to illustrate the clinical trial structure.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
18
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
19
The slide details the statistical powering and success thresholds for a clinical trial design.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) shift the curve to the left compared to 24 hours, indicating higher potency/efficacy with sustained exposure.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
21
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
22
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
23
Waterfall plot shows 10 patients; 8 show reduction in tumor burden.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
25
The slide uses a combination of molecular mechanism diagrams, bar charts, PET scans, and dot plots to explain the biological rationale for a drug's efficacy.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
26
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
27
Includes molecular structure of ONC206 and protein structures of targets DRD2 and ClpP.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
28
Includes citations for specific cancer models and experimental data.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
29
The slide uses in vitro cell viability data and PK modeling to justify a dose intensification strategy.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
30
Includes logos for NIH and Pacific Pediatric Neuro-Oncology Consortium.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
31
Includes footnote references for data sources and royalty obligations.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations Beat · Market Size1 hit
33
The slide shows a bioluminescence imaging comparison of tumor burden in mice treated with Vehicle, ONC201, and ONC212.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
34
The chart shows a clear dose-response/time-response relationship for viral load reduction.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
35
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
36
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
37
The slide uses a process-flow diagram to link financial strength to clinical milestones.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations Beat · FinancialsLoop · Why Now1 hit
38
Chimerix | Investor Presentation Deck | 38 slidesChimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
01
Cipher Mining | Investor Presentation Deck | 12 slidesCipher Mining | Investor Presentation Deck | 12 slides · Cipher Mining
Pitch deck Investor relations 1 hit
03
Cipher Mining | Investor Presentation Deck | 12 slidesCipher Mining | Investor Presentation Deck | 12 slides · Cipher Mining
Pitch deck Investor relations 1 hit
05
The slide uses a dark-themed dashboard layout with distinct cards for operational and financial KPIs.Cipher Mining | Investor Presentation Deck | 12 slides · Cipher Mining
Pitch deck Investor relations 1 hit
06
The slide highlights operational status of three data centers and provides a bar chart for hash rate growth.Cipher Mining | Investor Presentation Deck | 12 slides · Cipher Mining
Pitch deck Investor relations 1 hit
07
Includes aerial photography of the facility and detailed footnotes regarding joint venture ownership and cost calculations.Cipher Mining | Investor Presentation Deck | 12 slides · Cipher Mining
Pitch deck Investor relations 1 hit
08
Includes site photos and detailed footnotes explaining ownership and calculation methodology.Cipher Mining | Investor Presentation Deck | 12 slides · Cipher Mining
Pitch deck Investor relations 1 hit